These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 22110661)

  • 1. Computational modeling of interactions between multiple myeloma and the bone microenvironment.
    Wang Y; Pivonka P; Buenzli PR; Smith DW; Dunstan CR
    PLoS One; 2011; 6(11):e27494. PubMed ID: 22110661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pathogenesis of the bone disease of multiple myeloma.
    Edwards CM; Zhuang J; Mundy GR
    Bone; 2008 Jun; 42(6):1007-13. PubMed ID: 18406675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting the impact of combined therapies on myeloma cell growth using a hybrid multi-scale agent-based model.
    Ji Z; Su J; Wu D; Peng H; Zhao W; Nlong Zhao B; Zhou X
    Oncotarget; 2017 Jan; 8(5):7647-7665. PubMed ID: 28032590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the bone microenvironment in multiple myeloma.
    Roodman GD
    J Bone Miner Metab; 2010 May; 28(3):244-50. PubMed ID: 20127498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological aspects of altered bone remodeling in multiple myeloma and possibilities of pharmacological intervention.
    Kupisiewicz K
    Dan Med Bull; 2011 May; 58(5):B4277. PubMed ID: 21535989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple myeloma in the marrow: pathogenesis and treatments.
    Fairfield H; Falank C; Avery L; Reagan MR
    Ann N Y Acad Sci; 2016 Jan; 1364(1):32-51. PubMed ID: 27002787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-host cell interactions in the bone disease of myeloma.
    Fowler JA; Edwards CM; Croucher PI
    Bone; 2011 Jan; 48(1):121-8. PubMed ID: 20615487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis and management of bone lesions in multiple myeloma.
    Bataille R; Manolagas SC; Berenson JR
    Hematol Oncol Clin North Am; 1997 Apr; 11(2):349-61. PubMed ID: 9137974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the bone marrow microenvironment in multiple myeloma.
    Roodman GD
    J Bone Miner Res; 2002 Nov; 17(11):1921-5. PubMed ID: 12412796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interaction between myeloma cells and bone tissue].
    Seckinger A; Hose D
    Radiologe; 2014 Jun; 54(6):545-50. PubMed ID: 24832128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone and paraproteinemias.
    Zangari M; Zhan F; Tricot G
    Curr Opin Support Palliat Care; 2010 Sep; 4(3):195-9. PubMed ID: 20657285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow stromal cells create a permissive microenvironment for myeloma development: a new stromal role for Wnt inhibitor Dkk1.
    Fowler JA; Mundy GR; Lwin ST; Edwards CM
    Cancer Res; 2012 May; 72(9):2183-9. PubMed ID: 22374979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microenvironmental influence on pre-clinical activity of polo-like kinase inhibition in multiple myeloma: implications for clinical translation.
    McMillin DW; Delmore J; Negri J; Ooi M; Klippel S; Miduturu CV; Gray NS; Richardson PG; Anderson KC; Kung AL; Mitsiades CS
    PLoS One; 2011; 6(7):e20226. PubMed ID: 21750699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing Wnt signaling in the bone marrow microenvironment inhibits the development of myeloma bone disease and reduces tumor burden in bone in vivo.
    Edwards CM; Edwards JR; Lwin ST; Esparza J; Oyajobi BO; McCluskey B; Munoz S; Grubbs B; Mundy GR
    Blood; 2008 Mar; 111(5):2833-42. PubMed ID: 18094333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The multiple myeloma bone eco-system and its relation to oncogenesis.
    Bataille R
    Morphologie; 2015 Jun; 99(325):31-7. PubMed ID: 26005000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissecting the multiple myeloma-bone microenvironment reveals new therapeutic opportunities.
    Shay G; Hazlehurst L; Lynch CC
    J Mol Med (Berl); 2016 Jan; 94(1):21-35. PubMed ID: 26423531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A loss of host-derived MMP-7 promotes myeloma growth and osteolytic bone disease in vivo.
    Lwin ST; Fowler JA; Drake MT; Edwards JR; Lynch CC; Edwards CM
    Mol Cancer; 2017 Feb; 16(1):49. PubMed ID: 28241871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteoblast function in myeloma.
    Roodman GD
    Bone; 2011 Jan; 48(1):135-40. PubMed ID: 20601285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of the bone marrow microenvironment in the pathogenesis of multiple myeloma].
    Jurczyszyn A; Gdula-Argasińska J; Kosmaczewska A; Skotnicki AB
    Postepy Hig Med Dosw (Online); 2015 Apr; 69():521-33. PubMed ID: 25983291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple myeloma: the bone marrow microenvironment and its relation to treatment.
    Andrews SW; Kabrah S; May JE; Donaldson C; Morse HR
    Br J Biomed Sci; 2013; 70(3):110-20. PubMed ID: 24273897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.